Leishmania major Dihydrolipoyl dehydrogenase (DLD) is a key metabolic enzyme that drives parasite proliferation, pathology and host immune response. [PDF]
Onwah SS +9 more
europepmc +1 more source
Zinc selenide (ZnSe) nanoparticle coated with green seaweed (Ulva fasciata) hydroalcoholic extract as an anti-leishmanial compound on Leishmania major. [PDF]
Atef Z +5 more
europepmc +1 more source
Comment on "A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study". [PDF]
Majidiani H, Hosseini SA.
europepmc +1 more source
Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by <i>Leishmania major</i>. [PDF]
Hassani-Abharian P +3 more
europepmc +1 more source
Response Comment on "A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study". [PDF]
Pirmoradi S +4 more
europepmc +1 more source
Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc. [PDF]
Fadaie M, Shahmoradi Z, Khanahmad H.
europepmc +1 more source
Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major. [PDF]
Bhusal CK +6 more
europepmc +1 more source
Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. [PDF]
Saberi M +8 more
europepmc +1 more source
Dogs may carry Leishmania tropica and Leishmania major in their blood circulation: a molecular and hematological study. [PDF]
Rezaei A +4 more
europepmc +1 more source
A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study. [PDF]
Pirmoradi S +4 more
europepmc +1 more source

